K

Kadimastem Ltd
TASE:KDST

Watchlist Manager
Kadimastem Ltd
TASE:KDST
Watchlist
Price: 2 794 ILS -1.13% Market Closed
Market Cap: 117.9m ILS

Operating Margin
Kadimastem Ltd

0%
Current
0%
Average
-4.2%
Industry

Operating Margin represents how efficiently a company is able to generate profit through its core operations.

Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.

Operating Margin
0%
=
Operating Profit
-7.6m
/
Revenue
0

Operating Margin Across Competitors

No Stocks Found

Kadimastem Ltd
Glance View

Market Cap
117.9m ILS
Industry
Biotechnology

Kadimastem Ltd. is a clinical-stage bio-pharmaceutical company engaging in the development of industrial regenerative medicine therapies based on differentiated cells derived from Human Embryonic Stem Cells to treat neurology-degenerative diseases. The Company’s technology enables the differentiation of stem cells into insulin secreting beta cells, as well as a range of neural cells (including Oligodendrocytes, Astrocytes). The firm produces islet-like clusters that show glucose-stimulated insulin secretion. In addition, the Company is partnering with pharmaceutical companies interested to screen potential drug compounds (hit-lead, lead optimization) on its stem-cell derived cells, primarily oligodendrocytes and astrocytes.

KDST Intrinsic Value
Not Available
K
What is Operating Margin?

Operating Margin represents how efficiently a company is able to generate profit through its core operations.

Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.

Operating Margin
0%
=
Operating Profit
-7.6m
/
Revenue
0
What is the Operating Margin of Kadimastem Ltd?

Based on Kadimastem Ltd's most recent financial statements, the company has Operating Margin of 0%.

Back to Top